Records containing: Idiopathic Pulmonary Fibrosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-03-24Efficacy and Safety of Intravenous Infusion of SHR-1906 in Patients With Idiopathic Pulmonary Fibrosis: a Multicenter, Randomized, Double-blind, Parallel Placebo-controlled Phase II Trial
-
CLINICAL_TRIALS study record update · 2025-03-20A Randomized, Open-Label, Single-Dose, Double-period, Double-Crossover Comparative Study on the Pharmacokinetics of Pirfenidone Modified-Release Tablets by Oral Administration in Healthy Chinese Subjects Under Fasting and Fed Conditions
-
CLINICAL_TRIALS study record update · 2025-03-11Molecular Diagnosis of Idiopathic Interstitial Pneumonias: a Prospective Study
-
CLINICAL_TRIALS study record update · 2025-03-10Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2025-03-05Phase 2 Study of Long Acting Octreotide in Idiopathic Pulmonary Fibrosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-03-04Evaluation of the Value of 18F-Fluoromisonidazole (18F-FMISO) Positron Emission Tomography Hypoxia Imaging in Idiopathic Pulmonary Fibrosis - a Non-randomized Proof-of-concept Study Comparing Patients with Idiopathic Pulmonary Fibrosis and Healthy Subjects
-
CLINICAL_TRIALS study record update · 2025-02-18A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Parallel Group Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK3915393 Administered as a Single Dose to Healthy Participants of Chinese, Japanese and European Ancestry, and to Assess the Effects of GSK3915393, on the Pharmacokinetics of Nintedanib
-
CLINICAL_TRIALS study record update · 2025-02-04Detection of Integrin avb6 in Idiopathic Pulmonary Fibrosis, Primary Sclerosing Cholangitis, and Coronavirus Disease 2019 With [18F]FP-R01-MG-F2 With PET/CT
-
CLINICAL_TRIALS study record update · 2025-01-31A Double-blind, Placebo-controlled, Randomised, First in Human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Oral Doses of C106 in Healthy Male and Female Subjects
-
CLINICAL_TRIALS study record update · 2025-01-31Yoga Effect on Quality of Life Study Among Patients with Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2025-01-17High Oxygen Delivery to Preserve Exercise Capacity in IPF Patients Treated With Nintedanib: The HOPE-IPF Study
-
CLINICAL_TRIALS study record update · 2025-01-16Investigating the Role of Skeletal Muscle Dysfunction on Dyspnea and Exercise Intolerance in Interstitial Lung Disease
-
CLINICAL_TRIALS study record update · 2024-12-13A Randomized, Double-blind, Placebo-controlled, Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of Garadacimab in Subjects With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2024-12-12A Multicenter, Randomized, Double-Blind,Placebo-controlled,Phase 2 Study of Jaktinib Hydrochloride Tablets in Participants With Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2024-12-11Prospective, Observational Study of the Factors Affecting Patient and Physician Perceptions of Quality of Life in Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2024-12-10A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of GKT137831 in Patients with Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2024-12-0923andMe Idiopathic Pulmonary Fibrosis Research Study
-
CLINICAL_TRIALS study record update · 2024-12-02A Phase 2, Multi-Center Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
-
CLINICAL_TRIALS study record update · 2024-11-22Precision Diagnosis and Care for Families With Pulmonary Fibrosis in Ireland [PRECISE-PF]
-
CLINICAL_TRIALS study record update · 2024-11-19A Randomized, Double-blind, Placebo-controlled Phase II/III Trial Evaluating the Efficacy and Safety of Sufenidone (SC1011) Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF).
-
CLINICAL_TRIALS study record update · 2024-11-04A Randomized, Double-blinded, Placebo-controlled, Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of SRN-001 in Healthy Participants
-
CLINICAL_TRIALS study record update · 2024-10-31Determination of Functional Exercise Capacity, Peripheral Muscle Strength, Respiratory Muscle Endurance and Parameters Affecting Quality of Life in Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2024-10-15The Special Drug Use-results Survey (All-Case Surveillance) of Ofev® Capsules in Patients With Idiopathic Pulmonary Fibrosis (IPF) in Japan
-
CLINICAL_TRIALS study record update · 2024-10-08Current Status of Diagnosis, Treatment and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis
-
CLINICAL_TRIALS study record update · 2024-10-01Economic Burden Associated With Nintedanib Non-adherence Among Medicare Beneficiaries With IPF